Skip to main content

MARSHALL WACE, LLP

Position in PCRX — Pacira BioSciences, Inc.

CIK 1318757 LONDON, X0

Position in PCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,281,558
-$1,268,188 QoQ
Shares Held
129,348
-32.1% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 254 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. PCRX ranks #16 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCRX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,281,558 129,348
2025-06-30 $4,549,746 190,366
2024-12-31 $802,828 42,613
2024-09-30 $7,900,481 524,949
2024-06-30 $27,784,400 971,143
2024-03-31 $23,707,704 811,352
2023-12-31 $16,201,711 480,193
2023-09-30 $14,899,587 485,645
2023-06-30 $15,559,060 388,297
2023-03-31 $13,024,960 319,161
2022-12-31 $4,840,033 125,357
2022-09-30 $2,285,095 42,961
2022-06-30 $1,068,230 18,323
2021-12-31 $12,354,224 205,322
2021-09-30 $836,696 14,941
2021-03-31 $2,146,436 30,624